Search results for "GLAUCOMA"

showing 10 items of 317 documents

Ansia,stili di coping e danno campimetrico in pazienti con Glaucoma cronico ad angolo aperto

2011

Settore MED/30 - Malattie Apparato VisivoGlaucoma cronico ad angolo aperto ansiastili di coping campo visivo
researchProduct

OCT e GDx VCC : nella diagnosi e nel follow-up

2009

Considerando che è sempre meglio prevenire che curare, l'autore evidenzia l'importanza dell'OCT e del GDx VCC rispetto alla perimetria computerizzata .Il danno del Campo Visivo, infatti, nella perimetria computerizzata non è mai precoce, pertanto, il difetto della funzione visiva si rileva quando è presente già un danno avanzato anatomico. l'OCT e il GDx VCC mediante il software permettono,invece, l'analisi dell'RNFL che precedono di almeno 5 anni le alterazioni perimetriche.

Settore MED/30 - Malattie Apparato VisivoGlaucoma pre-perimetrico OCT GDx VCC analisi dell'RNFL
researchProduct

Neuroprotezione del paziente con glaucoma cronico ad angolo aperto:ruolo della Citicolina in soluzione orale

2011

Aim: To verify the efficacy of Citicoline, taken orally, in the prevention of neurological damage in patients with Chronic Open Angle Glaucoma (COA G). Methods: 30 subjects with COA G were divided into 2 groups: 18 subjects (CT group) were treated with Citicoline and 12 (PP group) were treated with placebo. Both groups underwent 3 cycles of treatment. A cycle lasted 60 days and after every cycle there was a wash-out period of 30 days. On day 0, 60, 90, 150, 180, 240 and 270 all subjects underwent an examination of the optic nerve fibres by GDx VVC and a simultaneous recording of pattern reversal VEP s and pattern ER G. Results: In both groups endocular pressure values kept steady below 21 m…

Settore MED/30 - Malattie Apparato VisivoGlaucomaCiticolinaNeuroprotection
researchProduct

High-Tech: quando e perchè

2008

l'autore ,dopo un breve excursus delle tecniche high-tech in uso in oftalmologia, specie nella diagnosi precoce del glaucoma, introduce il dibattito su quanto queste possono considerarsi utili anche ai fini terapeutici.

Settore MED/30 - Malattie Apparato VisivoOCT GDx VCC Perimetria Glaucoma
researchProduct

Visual field defects,type A personality,anxiety and coping styles in patients with primary open angle Glaucoma

2012

Settore MED/30 - Malattie Apparato VisivoVisual field defects type A personalityanxiety coping style primary open angle Glaucoma
researchProduct

Bevacizumab intravitreale e trabeculectomia con mitomicina C nel trattamento del glaucoma neovascolare

2011

Settore MED/30 - Malattie Apparato Visivotrabeculectomia con MMCbevacizumab intravitrealeglaucoma neovascolare
researchProduct

Modulazione della risposta fibroblastica

2012

Settore MED/30 - Malattie Apparato Visivotrabeculectomiamitomicina CChirurgia del glaucoma
researchProduct

Cataratta e glaucoma: cosa cambia nella chirurgia della cataratta ? E in quella del glaucoma ?

2008

TIMING CHIRURGICOTIMINGSettore MED/30 - Malattie Apparato VisivoCHIRURGIA CATARATTACHIRURGIA DEL GLAUCOMACHIRURGIA DELLA CATARATTACHIRURGIA GLAUCOMA
researchProduct

Effect of an oral supplementation with a formula containing R-lipoic acid in glaucoma patients

2020

Abstract Objective To analyse the safety and effectiveness of the oral administration of a commercialised supplement containing R-alpha lipoic acid (ALA), taurine, vitamins C and E, lutein, zeaxanthin, zinc, copper and docosahexaenoic acid (DHA), in patients with primary open angle glaucoma (POAG), and in control subjects. Material and methods A prospective study of cases and controls was carried out, including 30 participants of both genders that were divided into: POAG Group (n = 15) and a control group (CG; n = 15), assigned to the oral intake of NuaDHA preparations Vision® (1 pill/day) + NuaDHA 1000 (2 pills/day) for 6 months. Participants were interviewed, ophthalmologically examined, …

Taurinemedicine.medical_specialtygenetic structuresbusiness.industryGlaucomaGeneral MedicineMalondialdehydemedicine.diseaseGastroenterologyeye diseaseschemistry.chemical_compoundLipoic acidchemistryIntolerancesOral administrationDocosahexaenoic acidInternal medicinemedicinebusinessProspective cohort studyArchivos de la Sociedad Española de Oftalmología (English Edition)
researchProduct

Safety and efficacy of changing to the travoprost/timolol maleate fixed combination (DuoTrav) from prior mono- or adjunctive therapy.

2010

Norbert Pfeiffer1, Maria-Luise Scherzer2, Hubert Maier3, Sonja Schoelzel4, Mark C Jasek5, Jeanette A Stewart6, William C Stewart6 On behalf of the DuoTravMED study group1Johannes Gutenberg-Universität Mainz, Mainz, Germany; 2Regenstauf, Germany; 3Gerolzhofen, Germany; 4Institutes of Molecular Medicine, University of Freiburg, Department of Surgery, Freiburg, Germany; 5Alcon Laboratories, Inc., Fort Worth, TX, USA; 6PRN Pharmaceutical Research Network, LLC, Charleston, SC, USAPurpose: To assess the safety and efficacy of changing to the travoprost/timolol fixed combination (TTFC) from other mono- or adjunctive therapies.Patients and methods: A prospective, open-label, observational …

Timolol maleatesafetyIntraocular pressuremedicine.medical_specialtyprimary open-angle glaucomagenetic structuresbusiness.industrytravoprost/timolol fixed combinationefficacyTimololOcular hypertensionClinical Ophthalmologymedicine.diseaseeye diseasesOphthalmologyOphthalmologymedicineocular hypertensionTravoprostsense organsskin and connective tissue diseasesbusinessmedicine.drugOriginal Researchintraocular pressureClinical ophthalmology (Auckland, N.Z.)
researchProduct